Use of Okadaic Acid to Identify Relevant Phosphoepitopes in Pathology: A Focus on Neurodegeneration

Use of Okadaic Acid to Identify Relevant Phosphoepitopes in Pathology: A Focus on Neurodegeneration

Protein phosphorylation is involved in the regulation of a wide variety of physiological processes and is the result of a balance between protein kinase and phosphatase activities. Biologically active marine derived compounds have been shown to represent an interesting source of novel compounds that...

Full description

Bibliographic Details
Main Authors:	Jesús Avila, Miguel Medina, Nieves Villanueva
Format:	Article
Language:	English
Published:	MDPI AG 2013-05-01
Series:	Marine Drugs
Subjects:	Alzheimer GSK-3 kinases neurodegeneration okadaic acid phosphatases phosphorylation PP2A tangles tau
Online Access:	http://www.mdpi.com/1660-3397/11/5/1656

Similar Items

Okadaic acid induces damage of human neuroblastoma cell line SH-SY5Y
by: LU Ya-lan, ZHOU Li, HAN Yun-lin, WANG Ke-wei, QIN Chuan
Published: (2022-06-01)

Okadaic Acid: A Tool to Study the Hippo Pathway
by: Yutaka Hata, et al.
Published: (2013-03-01)

Okadaic acid did not change the nitrate reductase activation state in tomato seedlings
by: A. KOŁTON, et al.
Published: (2022-08-01)

GSK-3 and Tau: A Key Duet in Alzheimer’s Disease
by: Carmen Laura Sayas, et al.
Published: (2021-03-01)

Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures
by: Carolyn A. Rankin, et al.
Published: (2008-09-01)

Is Protein Phosphatase Inhibition Responsible for the Toxic Effects of Okadaic Acid in Animals?
by: Rex Munday
Published: (2013-02-01)

Okadaic Acid: More than a Diarrheic Toxin
by: Josefina Méndez, et al.
Published: (2013-10-01)

Impact of APOE genotype on prion-type propagation of tauopathy
by: Tristan Williams, et al.
Published: (2022-04-01)

Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid
by: Bettina M. Foidl, et al.
Published: (2018-04-01)

A Protein Phosphatase 2A-Based Assay to Detect Okadaic Acids and Microcystins
by: Tsuyoshi Ikehara, et al.
Published: (2024-01-01)

Single Laboratory Validation of A Ready-to-Use Phosphatase Inhibition Assay for Detection of Okadaic Acid Toxins
by: Luis Mata, et al.
Published: (2012-04-01)

Self-Association of Okadaic Acid: Structural and Pharmacological Significance
by: José J. Fernández, et al.
Published: (2013-05-01)

GSK-3β, a pivotal kinase in Alzheimer disease
by: Maria eLLorens-Martin, et al.
Published: (2014-05-01)

Pathology of different tau protein species in neurodegenerative diseases: Alzheimer’s disease, corticobasal degeneration, and progressive supranuclear palsy
by: Mohammad Majidi, et al.
Published: (2021-07-01)

Association between lower body temperature and increased tau pathology in cognitively normal older adults
by: Esther M. Blessing, et al.
Published: (2022-09-01)

Effects of intrahippocampal administration of the phosphatase inhibitor okadaic acid: Dual effects on memory formation
by: Monica R.M. Vianna, et al.

Neurotrophin receptor p75 mediates amyloid β-induced tau pathology
by: Lin-Lin Shen, et al.
Published: (2019-12-01)

Okadaic Acid Toxin at Sublethal Dose Produced Cell Proliferation in Gastric and Colon Epithelial Cell Lines
by: Miguel del Campo, et al.
Published: (2013-12-01)

Modulation of GSK-3 as a therapeutic strategy on Tau pathologies
by: Miguel eMedina, et al.
Published: (2011-10-01)

Overexpression of GSK-3β in Adult Tet-OFF GSK-3β Transgenic Mice, and Not During Embryonic or Postnatal Development, Induces Tau Phosphorylation, Neurodegeneration and Learning Deficits
by: Alberto Rodríguez-Matellán, et al.
Published: (2020-09-01)

Defined Tau Phosphospecies Differentially Inhibit Fast Axonal Transport Through Activation of Two Independent Signaling Pathways
by: Sarah L. Morris, et al.
Published: (2021-01-01)

Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β
by: Giulia Povellato, et al.
Published: (2013-11-01)

PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107
by: Holly Fowle, et al.
Published: (2021-10-01)

Structure–Activity Relationship Studies Using Natural and Synthetic Okadaic Acid/Dinophysistoxin Toxins
by: Michael J. Twiner, et al.
Published: (2016-11-01)

Melatonin Rescues the Dendrite Collapse Induced by the Pro-Oxidant Toxin Okadaic Acid in Organotypic Cultures of Rat Hilar Hippocampus
by: Héctor Solís-Chagoyán, et al.
Published: (2020-11-01)

Identification of Dynamic Changes in Proteins Associated with the Cellular Cytoskeleton after Exposure to Okadaic Acid
by: Peter Roepstorff, et al.
Published: (2013-05-01)

Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer's disease
by: Ai-Hua Xu, et al.
Published: (2018-01-01)

Protein phosphorylation in neurodegeneration: friend or foe?
by: Sandra eTenreiro, et al.
Published: (2014-05-01)

Hyperphosphorylated tau targeting human serum albumin Fusion protein as therapeutics for Alzheimer’s diseases
by: Sookhee Bang, et al.
Published: (2024-12-01)

Neurodegeneration Within the Amygdala Is Differentially Induced by Opioid and HIV-1 Tat Exposure
by: Sara R. Nass, et al.
Published: (2022-05-01)

Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogaster
by: Kyu-Ho Shim, et al.
Published: (2019-10-01)

Simple Diffusion as the Mechanism of Okadaic Acid Uptake by the Mussel Digestive Gland
by: Juan Blanco, et al.
Published: (2019-07-01)

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia
by: Kunie Ando, et al.
Published: (2020-06-01)

Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons
by: Matias Ryding, et al.
Published: (2021-04-01)

In Vitro Interactions between Okadaic Acid and Rat Gut Microbiome
by: Yang Liu, et al.
Published: (2022-08-01)

Loss of Smek1 Induces Tauopathy and Triggers Neurodegeneration by Regulating Microtubule Stability
by: Ruo‐Nan Duan, et al.
Published: (2024-10-01)

Utilizing zebrafish and okadaic acid to study Alzheimer’s disease
by: Daniel Koehler, et al.
Published: (2018-01-01)

Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity
by: Taha F. S. Ali, et al.
Published: (2022-03-01)

Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model
by: Yasumasa Yoshiyama, et al.
Published: (2012-01-01)

Neuronal Excitation Induces Tau Protein Dephosphorylation via Protein Phosphatase 1 Activation to Promote Its Binding with Stable Microtubules
by: Sosuke Yagishita, et al.
Published: (2024-06-01)